Allogene Therapeutics Appoints Earl Douglas as General Counsel
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today... -Today at 08:31 am- MarketScreener
Gotshal Manges David Chang Pearl Douglas Christine Cassiano Wilson Sonsini Goodrich Rosati Lillian Smith
Source: marketscreener.com